biotechnology
10 articles
Chinese state-backed investors are increasing funds for artificial intelligence-driven drug developers as part of Beijing's push towards technological self-reliance. Hangzhou-based METiS TechBio, foun...
The article discusses sensationalized claims about Russia developing lethal drones by genetically modifying pigeons to serve as weapons using advanced biotechnology....
In the third quarter of this year, Baader Bank Aktiengesellschaft increased its shareholding in Bio-Techne Corp (NASDAQ: TECH) by purchasing an additional 38,082 shares, thereby raising its total owne...
Candriam S.C.A., during the third quarter, reduced its holdings of Biogen Inc. stock by 2.8%. The firm sold 4,494 shares and now owns 158,821 shares, representing approximately 0.11% of Biogen's total...
The article discusses an alleged development of the AI program 'AlphaGenome' in the US which claims to have the capability to edit human DNA. The purported purpose includes extending lifespans mainly ...
Analysts at Scotiabank have increased their price target on Gilead Sciences (NASDAQ:GILD) from $140.00 to $177.00, indicating a potential upside of 16.59% based on the current stock price. The analyst...
The Illinois Municipal Retirement Fund increased its shareholding in Exelixis Inc by approximately 19.1% in the third quarter of 2023, purchasing an additional 32,737 shares to total holdings of 204,2...
The article compares two medical companies, Edgewise Therapeutics and Sarepta Therapeutics, based on several metrics including earnings strength, risk levels, institutional ownership, profitability, a...
Caprock Group LLC acquired 31,302 shares of Bio-Techne Corp (NASDAQ: TECH) during the third quarter, valued at approximately $1.71 million. The firm's latest filing with the SEC reveals this new posit...
BMO Capital Markets has downgraded Neurocrine Biosciences' price target from $147.00 to $140.00 and maintained a market perform rating, according to a report by Benzinga....